Pharma Market Access
The Unitary Patent and the Unified Patent Court: possible opening in second half of 2022 will mean a complex European patent patchwork
A unified system of European patents has been a goal of those working towards European integration since before the establishment…
Brazil finally edges towards first drug pricing reform after two years – is it a missed opportunity?
In our recent blog on trends in international reference pricing (IRP), we mentioned that a public consultation was underway in Brazil on…
Barriers to market access for innovative medicines increase in the COVID era
The coronavirus disease 2019 (COVID-19) pandemic and governments responses are still impacting the pharmaceutical market globally, according to our latest…
What the Aduhelm backlash may mean for pharma pricing in the ‘new normal’
The ongoing controversy over Biogen's Aduhelm treatment shows that pricing scrutiny has risen to a new level. The backlash after…
Vaccine trade becomes a key factor in global diplomacy
The highly transmissible COVID-19 Delta variant highlights the importance of vaccines to both health and economic recovery, with widespread vaccination…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Northern Ireland: A case study for drug pricing controls vs free pricing
Generic drug manufacturers have warned that up to 90% of drugs currently supplied to Northern Ireland may be threatened with withdrawal as…
Pharmaceutical crisis deepens in Lebanon as central bank unable to meet cost of subsidized medicines
For international pharmaceutical companies, Lebanon has long been a small but important export market. Until recently, at around 50% of…
The UK’s first drug approval via Project Orbis – pulling away from the EMA strings?
In early May, the UK Medicines and Healthcare Products Regulatory Agency (MHRA) approved a targeted anticancer drug, AstraZeneca's Tagrisso (osimertinib),…
Reference pricing in CEE countries puts downward pressure on prices
Pharmaceutical prices in central and eastern European (CEE) countries tend to be low and drop over time - a double…
US announces support of COVID-19 vaccine IP waiver
In a highly significant move, the US government has announced its backing for a waiver on intellectual property (IP) protection…